Clinical Trial Results:
BTOG2: A British Thoracic Oncology Group phase III trial of gemcitabine plus cisplatin at 80 mg/m2 versus gemcitabine plus cisplatin at 50 mg/m2 versus gemcitabine plus carboplatin AUC 6 in stage IIIB/IV non-small cell lung cancer (NSCLC
Summary
|
|
EudraCT number |
2004-003868-30 |
Trial protocol |
IE GB |
Global completion date |
01 Apr 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
11 Aug 2019
|
First version publication date |
11 Aug 2019
|
Other versions |
|
Summary report(s) |
Ferry D et al European Journal of Cancer 2017 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.